Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 1.0
NantHealth, Inc. amended convertible notes of Not specified in excerpt with U.S. Bank Trust Company, National Association at Not specified in excerpt maturing Not specified in excerpt.
- Instrument
- convertible notes
- Principal
- Not specified in excerpt
- Counterparty
- U.S. Bank Trust Company, National Association
- Rate
- Not specified in excerpt
- Maturity
- Not specified in excerpt
- Event
- amendment
Exact text from the filing
On December 26, 2023, NantHealth, Inc. (the “ Company ”), NaviNet, Inc. and The OpenNMS Group, Inc. as subsidiary guarantors, and U.S. Bank Trust Company, National Association, as trustee and notes collateral agent, entered into a Second Supplemental Indenture (the “ Second Supplemental Indenture ”), which amends that certain Indenture, dated as of April 27, 2021 (as amended and restated by the First Supplemental Indenture, dated May 17, 2023, the “ Convertible Notes Indenture ”) to, among other things, (i) permit the transactions disclosed in the Company’s Current Report on Form 8-K filed on December 21, 2023 (the “ Highbridge Settlement ”), (ii) waive all Defaults and Events of Default (as each term is defined in the Convertible Notes Indenture) that have occurred or are occurring as of the date of the Second Supplemental Indenture, and (iii) increase flexibility for future Dispositions (as defined in the Convertible Notes Indenture).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
NantHealth, Inc. amended Second Supplemental Indenture to Convertible Notes Indenture dated April 27, 2021 with U.S. Bank Trust Company, National Association valued at Second Supplemental Indenture amends Convertible Notes Indenture to permit Highbridge Settlement, wa (effective 2023-12-26).
- Action
- amendment
- Agreement
- notes offering
- Counterparty
- U.S. Bank Trust Company, National Association
- Value
- Second Supplemental Indenture amends Convertible Notes Indenture to permit Highbridge Settlement, wa
- Effective
- 2023-12-26
Exact text from the filing
On December 26, 2023, NantHealth, Inc. (the “ Company ”), NaviNet, Inc. and The OpenNMS Group, Inc. as subsidiary guarantors, and U.S. Bank Trust Company, National Association, as trustee and notes collateral agent, entered into a Second Supplemental Indenture (the “ Second Supplemental Indenture ”), which amends that certain Indenture, dated as of April 27, 2021 (as amended and restated by the First Supplemental Indenture, dated May 17, 2023, the “ Convertible Notes Indenture ”) to, among other things, (i) permit the transactions disclosed in the Company’s Current Report on Form 8-K filed on December 21, 2023 (the “ Highbridge Settlement ”), (ii) waive all Defaults and Events of Default (as each term is defined in the Convertible Notes Indenture) that have occurred or are occurring as of the date of the Second Supplemental Indenture, and (iii) increase flexibility for future Dispositions (as defined in the Convertible Notes Indenture).
View on SEC.gov